Global Wound Care Biologics Supply, Demand and Key Producers, 2024-2030

Description

Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.   Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.

The global Wound Care Biologics market size is expected to reach $ 9005 million by 2030, rising at a market growth of 10.4% CAGR during the forecast period (2024-2030).

The wound care biologics market is experiencing significant growth and is expected to continue to expand in the coming years driven by the increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, as well as the growing geriatric population. The major sales regions for wound care biologics include North America, Europe, Asia Pacific, and Latin America. North America currently holds the largest market share, due to the presence of a well-established healthcare infrastructure and high adoption rates of advanced wound care products. Europe is also a key market for wound care biologics, with countries like Germany and the UK leading the way in terms of market penetration.

Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent. In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.

Despite the promising growth prospects, the wound care biologics market also faces several challenges. One of the key challenges is the high cost of biologics, which can limit access to these advanced wound care treatments for some patients. Additionally, regulatory hurdles and reimbursement issues can also pose challenges for companies operating in this space. However, there are also several opportunities for growth in the wound care biologics market. The increasing focus on personalized medicine and the development of novel biologic therapies are expected to drive market growth in the coming years. Additionally, the rising awareness about the benefits of biologics in wound healing and the growing demand for advanced wound care products in emerging markets present new opportunities for market expansion.

This report studies the global Wound Care Biologics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Wound Care Biologics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Wound Care Biologics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Wound Care Biologics total market, 2019-2030, (USD Million)
Global Wound Care Biologics total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Wound Care Biologics total market, key domestic companies, and share, (USD Million)
Global Wound Care Biologics revenue by player, revenue and market share 2019-2024, (USD Million)
Global Wound Care Biologics total market by Type, CAGR, 2019-2030, (USD Million)
Global Wound Care Biologics total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Wound Care Biologics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Smith and Nephew, Orthofix Medical, Organogenesis, MiMedx, Integra, Integra LifeSciences, Celularity, Amnio Technology, LLC, Skye Biologics, Pinnacle Transplant Technologies, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Wound Care Biologics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Wound Care Biologics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Wound Care Biologics Market, Segmentation by Type
    Biologic Skin Substitutes
    Enzyme Based Formulations
    Growth Factors

Global Wound Care Biologics Market, Segmentation by Application:
    Acute Wounds
    Chronic Wounds
    Surgical Wounds

Companies Profiled:
    Smith and Nephew
    Orthofix Medical
    Organogenesis
    MiMedx
    Integra
    Integra LifeSciences
    Celularity
    Amnio Technology, LLC
    Skye Biologics
    Pinnacle Transplant Technologies
    Convatec Group
    Stryker Corporation
    LifeNet Health
    Coloplast
    Tides Medical
    Imbed Biosciences
    NeXtGen Biologics
    Life Biologics
    Royal Biologics
    Merakris Therapeutics
    MediWound

Key Questions Answered
1. How big is the global Wound Care Biologics market?
2. What is the demand of the global Wound Care Biologics market?
3. What is the year over year growth of the global Wound Care Biologics market?
4. What is the total value of the global Wound Care Biologics market?
5. Who are the Major Players in the global Wound Care Biologics market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Wound Care Biologics Introduction
    1.2 World Wound Care Biologics Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Wound Care Biologics Total Market by Region (by Headquarter Location)
        1.3.1 World Wound Care Biologics Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Wound Care Biologics Revenue (2019-2030)
        1.3.3 China Based Company Wound Care Biologics Revenue (2019-2030)
        1.3.4 Europe Based Company Wound Care Biologics Revenue (2019-2030)
        1.3.5 Japan Based Company Wound Care Biologics Revenue (2019-2030)
        1.3.6 South Korea Based Company Wound Care Biologics Revenue (2019-2030)
        1.3.7 ASEAN Based Company Wound Care Biologics Revenue (2019-2030)
        1.3.8 India Based Company Wound Care Biologics Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Wound Care Biologics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Wound Care Biologics Consumption Value (2019-2030)
    2.2 World Wound Care Biologics Consumption Value by Region
        2.2.1 World Wound Care Biologics Consumption Value by Region (2019-2024)
        2.2.2 World Wound Care Biologics Consumption Value Forecast by Region (2025-2030)
    2.3 United States Wound Care Biologics Consumption Value (2019-2030)
    2.4 China Wound Care Biologics Consumption Value (2019-2030)
    2.5 Europe Wound Care Biologics Consumption Value (2019-2030)
    2.6 Japan Wound Care Biologics Consumption Value (2019-2030)
    2.7 South Korea Wound Care Biologics Consumption Value (2019-2030)
    2.8 ASEAN Wound Care Biologics Consumption Value (2019-2030)
    2.9 India Wound Care Biologics Consumption Value (2019-2030)

3 World Wound Care Biologics Companies Competitive Analysis
    3.1 World Wound Care Biologics Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Wound Care Biologics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Wound Care Biologics in 2023
        3.2.3 Global Concentration Ratios (CR8) for Wound Care Biologics in 2023
    3.3 Wound Care Biologics Company Evaluation Quadrant
    3.4 Wound Care Biologics Market: Overall Company Footprint Analysis
        3.4.1 Wound Care Biologics Market: Region Footprint
        3.4.2 Wound Care Biologics Market: Company Product Type Footprint
        3.4.3 Wound Care Biologics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Wound Care Biologics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Wound Care Biologics Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Wound Care Biologics Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Wound Care Biologics Consumption Value Comparison
        4.2.1 United States VS China: Wound Care Biologics Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Wound Care Biologics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Wound Care Biologics Companies and Market Share, 2019-2024
        4.3.1 United States Based Wound Care Biologics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Wound Care Biologics Revenue, (2019-2024)
    4.4 China Based Companies Wound Care Biologics Revenue and Market Share, 2019-2024
        4.4.1 China Based Wound Care Biologics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Wound Care Biologics Revenue, (2019-2024)
    4.5 Rest of World Based Wound Care Biologics Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Wound Care Biologics Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Wound Care Biologics Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Wound Care Biologics Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Biologic Skin Substitutes
        5.2.2 Enzyme Based Formulations
        5.2.3 Growth Factors
    5.3 Market Segment by Type
        5.3.1 World Wound Care Biologics Market Size by Type (2019-2024)
        5.3.2 World Wound Care Biologics Market Size by Type (2025-2030)
        5.3.3 World Wound Care Biologics Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Wound Care Biologics Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Acute Wounds
        6.2.2 Chronic Wounds
        6.2.3 Surgical Wounds
    6.3 Market Segment by Application
        6.3.1 World Wound Care Biologics Market Size by Application (2019-2024)
        6.3.2 World Wound Care Biologics Market Size by Application (2025-2030)
        6.3.3 World Wound Care Biologics Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Smith and Nephew
        7.1.1 Smith and Nephew Details
        7.1.2 Smith and Nephew Major Business
        7.1.3 Smith and Nephew Wound Care Biologics Product and Services
        7.1.4 Smith and Nephew Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Smith and Nephew Recent Developments/Updates
        7.1.6 Smith and Nephew Competitive Strengths & Weaknesses
    7.2 Orthofix Medical
        7.2.1 Orthofix Medical Details
        7.2.2 Orthofix Medical Major Business
        7.2.3 Orthofix Medical Wound Care Biologics Product and Services
        7.2.4 Orthofix Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Orthofix Medical Recent Developments/Updates
        7.2.6 Orthofix Medical Competitive Strengths & Weaknesses
    7.3 Organogenesis
        7.3.1 Organogenesis Details
        7.3.2 Organogenesis Major Business
        7.3.3 Organogenesis Wound Care Biologics Product and Services
        7.3.4 Organogenesis Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Organogenesis Recent Developments/Updates
        7.3.6 Organogenesis Competitive Strengths & Weaknesses
    7.4 MiMedx
        7.4.1 MiMedx Details
        7.4.2 MiMedx Major Business
        7.4.3 MiMedx Wound Care Biologics Product and Services
        7.4.4 MiMedx Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 MiMedx Recent Developments/Updates
        7.4.6 MiMedx Competitive Strengths & Weaknesses
    7.5 Integra
        7.5.1 Integra Details
        7.5.2 Integra Major Business
        7.5.3 Integra Wound Care Biologics Product and Services
        7.5.4 Integra Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Integra Recent Developments/Updates
        7.5.6 Integra Competitive Strengths & Weaknesses
    7.6 Integra LifeSciences
        7.6.1 Integra LifeSciences Details
        7.6.2 Integra LifeSciences Major Business
        7.6.3 Integra LifeSciences Wound Care Biologics Product and Services
        7.6.4 Integra LifeSciences Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Integra LifeSciences Recent Developments/Updates
        7.6.6 Integra LifeSciences Competitive Strengths & Weaknesses
    7.7 Celularity
        7.7.1 Celularity Details
        7.7.2 Celularity Major Business
        7.7.3 Celularity Wound Care Biologics Product and Services
        7.7.4 Celularity Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Celularity Recent Developments/Updates
        7.7.6 Celularity Competitive Strengths & Weaknesses
    7.8 Amnio Technology, LLC
        7.8.1 Amnio Technology, LLC Details
        7.8.2 Amnio Technology, LLC Major Business
        7.8.3 Amnio Technology, LLC Wound Care Biologics Product and Services
        7.8.4 Amnio Technology, LLC Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Amnio Technology, LLC Recent Developments/Updates
        7.8.6 Amnio Technology, LLC Competitive Strengths & Weaknesses
    7.9 Skye Biologics
        7.9.1 Skye Biologics Details
        7.9.2 Skye Biologics Major Business
        7.9.3 Skye Biologics Wound Care Biologics Product and Services
        7.9.4 Skye Biologics Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Skye Biologics Recent Developments/Updates
        7.9.6 Skye Biologics Competitive Strengths & Weaknesses
    7.10 Pinnacle Transplant Technologies
        7.10.1 Pinnacle Transplant Technologies Details
        7.10.2 Pinnacle Transplant Technologies Major Business
        7.10.3 Pinnacle Transplant Technologies Wound Care Biologics Product and Services
        7.10.4 Pinnacle Transplant Technologies Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Pinnacle Transplant Technologies Recent Developments/Updates
        7.10.6 Pinnacle Transplant Technologies Competitive Strengths & Weaknesses
    7.11 Convatec Group
        7.11.1 Convatec Group Details
        7.11.2 Convatec Group Major Business
        7.11.3 Convatec Group Wound Care Biologics Product and Services
        7.11.4 Convatec Group Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Convatec Group Recent Developments/Updates
        7.11.6 Convatec Group Competitive Strengths & Weaknesses
    7.12 Stryker Corporation
        7.12.1 Stryker Corporation Details
        7.12.2 Stryker Corporation Major Business
        7.12.3 Stryker Corporation Wound Care Biologics Product and Services
        7.12.4 Stryker Corporation Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Stryker Corporation Recent Developments/Updates
        7.12.6 Stryker Corporation Competitive Strengths & Weaknesses
    7.13 LifeNet Health
        7.13.1 LifeNet Health Details
        7.13.2 LifeNet Health Major Business
        7.13.3 LifeNet Health Wound Care Biologics Product and Services
        7.13.4 LifeNet Health Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 LifeNet Health Recent Developments/Updates
        7.13.6 LifeNet Health Competitive Strengths & Weaknesses
    7.14 Coloplast
        7.14.1 Coloplast Details
        7.14.2 Coloplast Major Business
        7.14.3 Coloplast Wound Care Biologics Product and Services
        7.14.4 Coloplast Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Coloplast Recent Developments/Updates
        7.14.6 Coloplast Competitive Strengths & Weaknesses
    7.15 Tides Medical
        7.15.1 Tides Medical Details
        7.15.2 Tides Medical Major Business
        7.15.3 Tides Medical Wound Care Biologics Product and Services
        7.15.4 Tides Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Tides Medical Recent Developments/Updates
        7.15.6 Tides Medical Competitive Strengths & Weaknesses
    7.16 Imbed Biosciences
        7.16.1 Imbed Biosciences Details
        7.16.2 Imbed Biosciences Major Business
        7.16.3 Imbed Biosciences Wound Care Biologics Product and Services
        7.16.4 Imbed Biosciences Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Imbed Biosciences Recent Developments/Updates
        7.16.6 Imbed Biosciences Competitive Strengths & Weaknesses
    7.17 NeXtGen Biologics
        7.17.1 NeXtGen Biologics Details
        7.17.2 NeXtGen Biologics Major Business
        7.17.3 NeXtGen Biologics Wound Care Biologics Product and Services
        7.17.4 NeXtGen Biologics Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 NeXtGen Biologics Recent Developments/Updates
        7.17.6 NeXtGen Biologics Competitive Strengths & Weaknesses
    7.18 Life Biologics
        7.18.1 Life Biologics Details
        7.18.2 Life Biologics Major Business
        7.18.3 Life Biologics Wound Care Biologics Product and Services
        7.18.4 Life Biologics Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.18.5 Life Biologics Recent Developments/Updates
        7.18.6 Life Biologics Competitive Strengths & Weaknesses
    7.19 Royal Biologics
        7.19.1 Royal Biologics Details
        7.19.2 Royal Biologics Major Business
        7.19.3 Royal Biologics Wound Care Biologics Product and Services
        7.19.4 Royal Biologics Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.19.5 Royal Biologics Recent Developments/Updates
        7.19.6 Royal Biologics Competitive Strengths & Weaknesses
    7.20 Merakris Therapeutics
        7.20.1 Merakris Therapeutics Details
        7.20.2 Merakris Therapeutics Major Business
        7.20.3 Merakris Therapeutics Wound Care Biologics Product and Services
        7.20.4 Merakris Therapeutics Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.20.5 Merakris Therapeutics Recent Developments/Updates
        7.20.6 Merakris Therapeutics Competitive Strengths & Weaknesses
    7.21 MediWound
        7.21.1 MediWound Details
        7.21.2 MediWound Major Business
        7.21.3 MediWound Wound Care Biologics Product and Services
        7.21.4 MediWound Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024)
        7.21.5 MediWound Recent Developments/Updates
        7.21.6 MediWound Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Wound Care Biologics Industry Chain
    8.2 Wound Care Biologics Upstream Analysis
    8.3 Wound Care Biologics Midstream Analysis
    8.4 Wound Care Biologics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Wound Care Biologics Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Wound Care Biologics Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Wound Care Biologics Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Wound Care Biologics Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Wound Care Biologics Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Wound Care Biologics Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Wound Care Biologics Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Wound Care Biologics Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Wound Care Biologics Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Wound Care Biologics Players in 2023
 Table 12. World Wound Care Biologics Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Wound Care Biologics Company Evaluation Quadrant
 Table 14. Head Office of Key Wound Care Biologics Players
 Table 15. Wound Care Biologics Market: Company Product Type Footprint
 Table 16. Wound Care Biologics Market: Company Product Application Footprint
 Table 17. Wound Care Biologics Mergers & Acquisitions Activity
 Table 18. United States VS China Wound Care Biologics Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Wound Care Biologics Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Wound Care Biologics Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Wound Care Biologics Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Wound Care Biologics Revenue Market Share (2019-2024)
 Table 23. China Based Wound Care Biologics Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Wound Care Biologics Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Wound Care Biologics Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Wound Care Biologics Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Wound Care Biologics Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Wound Care Biologics Revenue Market Share (2019-2024)
 Table 29. World Wound Care Biologics Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Wound Care Biologics Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Wound Care Biologics Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Wound Care Biologics Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Wound Care Biologics Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Wound Care Biologics Market Size by Application (2025-2030) & (USD Million)
 Table 35. Smith and Nephew Basic Information, Manufacturing Base and Competitors
 Table 36. Smith and Nephew Major Business
 Table 37. Smith and Nephew Wound Care Biologics Product and Services
 Table 38. Smith and Nephew Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Smith and Nephew Recent Developments/Updates
 Table 40. Smith and Nephew Competitive Strengths & Weaknesses
 Table 41. Orthofix Medical Basic Information, Manufacturing Base and Competitors
 Table 42. Orthofix Medical Major Business
 Table 43. Orthofix Medical Wound Care Biologics Product and Services
 Table 44. Orthofix Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Orthofix Medical Recent Developments/Updates
 Table 46. Orthofix Medical Competitive Strengths & Weaknesses
 Table 47. Organogenesis Basic Information, Manufacturing Base and Competitors
 Table 48. Organogenesis Major Business
 Table 49. Organogenesis Wound Care Biologics Product and Services
 Table 50. Organogenesis Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Organogenesis Recent Developments/Updates
 Table 52. Organogenesis Competitive Strengths & Weaknesses
 Table 53. MiMedx Basic Information, Manufacturing Base and Competitors
 Table 54. MiMedx Major Business
 Table 55. MiMedx Wound Care Biologics Product and Services
 Table 56. MiMedx Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. MiMedx Recent Developments/Updates
 Table 58. MiMedx Competitive Strengths & Weaknesses
 Table 59. Integra Basic Information, Manufacturing Base and Competitors
 Table 60. Integra Major Business
 Table 61. Integra Wound Care Biologics Product and Services
 Table 62. Integra Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Integra Recent Developments/Updates
 Table 64. Integra Competitive Strengths & Weaknesses
 Table 65. Integra LifeSciences Basic Information, Manufacturing Base and Competitors
 Table 66. Integra LifeSciences Major Business
 Table 67. Integra LifeSciences Wound Care Biologics Product and Services
 Table 68. Integra LifeSciences Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Integra LifeSciences Recent Developments/Updates
 Table 70. Integra LifeSciences Competitive Strengths & Weaknesses
 Table 71. Celularity Basic Information, Manufacturing Base and Competitors
 Table 72. Celularity Major Business
 Table 73. Celularity Wound Care Biologics Product and Services
 Table 74. Celularity Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Celularity Recent Developments/Updates
 Table 76. Celularity Competitive Strengths & Weaknesses
 Table 77. Amnio Technology, LLC Basic Information, Manufacturing Base and Competitors
 Table 78. Amnio Technology, LLC Major Business
 Table 79. Amnio Technology, LLC Wound Care Biologics Product and Services
 Table 80. Amnio Technology, LLC Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Amnio Technology, LLC Recent Developments/Updates
 Table 82. Amnio Technology, LLC Competitive Strengths & Weaknesses
 Table 83. Skye Biologics Basic Information, Manufacturing Base and Competitors
 Table 84. Skye Biologics Major Business
 Table 85. Skye Biologics Wound Care Biologics Product and Services
 Table 86. Skye Biologics Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Skye Biologics Recent Developments/Updates
 Table 88. Skye Biologics Competitive Strengths & Weaknesses
 Table 89. Pinnacle Transplant Technologies Basic Information, Manufacturing Base and Competitors
 Table 90. Pinnacle Transplant Technologies Major Business
 Table 91. Pinnacle Transplant Technologies Wound Care Biologics Product and Services
 Table 92. Pinnacle Transplant Technologies Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Pinnacle Transplant Technologies Recent Developments/Updates
 Table 94. Pinnacle Transplant Technologies Competitive Strengths & Weaknesses
 Table 95. Convatec Group Basic Information, Manufacturing Base and Competitors
 Table 96. Convatec Group Major Business
 Table 97. Convatec Group Wound Care Biologics Product and Services
 Table 98. Convatec Group Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. Convatec Group Recent Developments/Updates
 Table 100. Convatec Group Competitive Strengths & Weaknesses
 Table 101. Stryker Corporation Basic Information, Manufacturing Base and Competitors
 Table 102. Stryker Corporation Major Business
 Table 103. Stryker Corporation Wound Care Biologics Product and Services
 Table 104. Stryker Corporation Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. Stryker Corporation Recent Developments/Updates
 Table 106. Stryker Corporation Competitive Strengths & Weaknesses
 Table 107. LifeNet Health Basic Information, Manufacturing Base and Competitors
 Table 108. LifeNet Health Major Business
 Table 109. LifeNet Health Wound Care Biologics Product and Services
 Table 110. LifeNet Health Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. LifeNet Health Recent Developments/Updates
 Table 112. LifeNet Health Competitive Strengths & Weaknesses
 Table 113. Coloplast Basic Information, Manufacturing Base and Competitors
 Table 114. Coloplast Major Business
 Table 115. Coloplast Wound Care Biologics Product and Services
 Table 116. Coloplast Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 117. Coloplast Recent Developments/Updates
 Table 118. Coloplast Competitive Strengths & Weaknesses
 Table 119. Tides Medical Basic Information, Manufacturing Base and Competitors
 Table 120. Tides Medical Major Business
 Table 121. Tides Medical Wound Care Biologics Product and Services
 Table 122. Tides Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 123. Tides Medical Recent Developments/Updates
 Table 124. Tides Medical Competitive Strengths & Weaknesses
 Table 125. Imbed Biosciences Basic Information, Manufacturing Base and Competitors
 Table 126. Imbed Biosciences Major Business
 Table 127. Imbed Biosciences Wound Care Biologics Product and Services
 Table 128. Imbed Biosciences Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 129. Imbed Biosciences Recent Developments/Updates
 Table 130. Imbed Biosciences Competitive Strengths & Weaknesses
 Table 131. NeXtGen Biologics Basic Information, Manufacturing Base and Competitors
 Table 132. NeXtGen Biologics Major Business
 Table 133. NeXtGen Biologics Wound Care Biologics Product and Services
 Table 134. NeXtGen Biologics Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 135. NeXtGen Biologics Recent Developments/Updates
 Table 136. NeXtGen Biologics Competitive Strengths & Weaknesses
 Table 137. Life Biologics Basic Information, Manufacturing Base and Competitors
 Table 138. Life Biologics Major Business
 Table 139. Life Biologics Wound Care Biologics Product and Services
 Table 140. Life Biologics Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 141. Life Biologics Recent Developments/Updates
 Table 142. Life Biologics Competitive Strengths & Weaknesses
 Table 143. Royal Biologics Basic Information, Manufacturing Base and Competitors
 Table 144. Royal Biologics Major Business
 Table 145. Royal Biologics Wound Care Biologics Product and Services
 Table 146. Royal Biologics Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 147. Royal Biologics Recent Developments/Updates
 Table 148. Royal Biologics Competitive Strengths & Weaknesses
 Table 149. Merakris Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 150. Merakris Therapeutics Major Business
 Table 151. Merakris Therapeutics Wound Care Biologics Product and Services
 Table 152. Merakris Therapeutics Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 153. Merakris Therapeutics Recent Developments/Updates
 Table 154. Merakris Therapeutics Competitive Strengths & Weaknesses
 Table 155. MediWound Basic Information, Manufacturing Base and Competitors
 Table 156. MediWound Major Business
 Table 157. MediWound Wound Care Biologics Product and Services
 Table 158. MediWound Wound Care Biologics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 159. MediWound Recent Developments/Updates
 Table 160. MediWound Competitive Strengths & Weaknesses
 Table 161. Global Key Players of Wound Care Biologics Upstream (Raw Materials)
 Table 162. Global Wound Care Biologics Typical Customers


List of Figures
 Figure 1. Wound Care Biologics Picture
 Figure 2. World Wound Care Biologics Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Wound Care Biologics Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Wound Care Biologics Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Wound Care Biologics Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Wound Care Biologics Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Wound Care Biologics Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Wound Care Biologics Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Wound Care Biologics Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Wound Care Biologics Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Wound Care Biologics Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Wound Care Biologics Revenue (2019-2030) & (USD Million)
 Figure 13. Wound Care Biologics Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Wound Care Biologics Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Wound Care Biologics Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Wound Care Biologics Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Wound Care Biologics Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Wound Care Biologics Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Wound Care Biologics Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Wound Care Biologics Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Wound Care Biologics Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Wound Care Biologics Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Wound Care Biologics by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Wound Care Biologics Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Wound Care Biologics Markets in 2023
 Figure 27. United States VS China: Wound Care Biologics Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Wound Care Biologics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Wound Care Biologics Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Wound Care Biologics Market Size Market Share by Type in 2023
 Figure 31. Biologic Skin Substitutes
 Figure 32. Enzyme Based Formulations
 Figure 33. Growth Factors
 Figure 34. World Wound Care Biologics Market Size Market Share by Type (2019-2030)
 Figure 35. World Wound Care Biologics Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 36. World Wound Care Biologics Market Size Market Share by Application in 2023
 Figure 37. Acute Wounds
 Figure 38. Chronic Wounds
 Figure 39. Surgical Wounds
 Figure 40. World Wound Care Biologics Market Size Market Share by Application (2019-2030)
 Figure 41. Wound Care Biologics Industrial Chain
 Figure 42. Methodology
 Figure 43. Research Process and Data Source

Companies Mentioned

Smith and Nephew
Orthofix Medical
Organogenesis
MiMedx
Integra
Integra LifeSciences
Celularity
Amnio Technology, LLC
Skye Biologics
Pinnacle Transplant Technologies
Convatec Group
Stryker Corporation
LifeNet Health
Coloplast
Tides Medical
Imbed Biosciences
NeXtGen Biologics
Life Biologics
Royal Biologics
Merakris Therapeutics
MediWound